Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.76 USD | +8.86% | +15.16% | +11.37% |
05-03 | Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating | MT |
05-03 | Drugmaker Amneal agrees to $270 million U.S. opioid settlement | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.37% | 2.09B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals' Q2 Adjusted Earnings Fall, Revenue Rises